Ventricular Dysfunction, Left clinical trials at UCSF
1 research study open to eligible people
open to eligible people ages 18-100
A prospective, multi-center, dual-arm pivotal study of the BioVentrix Revivent TC System, with 2:1 study vs. active concurrent control group allocation ratio. This study will include 126 patients of which 84 patients will be treated with the investigational device and 42 patients will be included in an active control group.
San Francisco, California and other locations